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Background: Ubiquitin Specific Peptidase 39 (USP39) is a 65 kDa SR-related protein involved in RNA splicing. Previous
studies showed that USP39 is related with tumorigenesis of human breast cancer cells.
Results: In the present study, we investigated the functions of USP39 in human hepatocellular carcinoma (HCC) cell
line SMMC-7721. We knocked down the expression of USP39 through lentivirus mediated RNA interference. The results
of qRT-PCR and western blotting assay showed that both the mRNA and protein levels were suppressed efficiently after
USP39 specific shRNA was delivered into SMMC-7721 cells. Cell growth was significantly inhibited as determined by
MTT assay. Crystal violet staining indicated that colony numbers and sizes were both reduced after knock-down of
USP39. Furthermore, suppression of USP39 arrested cell cycle progression at G2/M phase in SMMC-7721cells. In addition,
Annexin V showed that downregulation of USP39 significantly increased the population of apoptotic cells.
Conclusions: All our results suggest that USP39 is important for HCC cell proliferation and is a potential target for
molecular therapy of HCC.
Keywords: Ubiquitin Specific Peptidase 39, Lentivirus, Human hepatocellular carcinoma, Cell proliferation, Cell cycleBackground
Human hepatocellular carcinoma (HCC) is the most
popular type of liver cancer, which is mainly caused by
viral infection [1-3]. It ranks as one of the top reasons of
cancer related death all over the world [4,5]. The high
rate of tumor recurrence and intrahepatic metastasis
lead to poor prognosis of HCC patients [2]. To find out
the molecules associated with HCC is very important for
therapy of HCC [6].
Recently, RNA interference (RNAi) has emerged as a
powerful tool to down-regulate the expression of target
genes in mammalian cells and animals, especially in can-
cer cells [7]. Lentiviral vectors taking small hairpin RNA
(shRNA) are found capable of silencing target gene ex-
pression with high specificity, stability and efficiency in a
variety of human cancer cells including HCC cells [8,9,6].* Correspondence: zeya_pan@yeah.net
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unless otherwise stated.RNA splicing plays key role in eukaryotic gene expres-
sion [10]. Mutations of splicing elements or changes of
activities could affect tumor genesis and progression
[11,12]. Ubiquitin Specific Peptidase 39 (USP39) is a
65 kDa SR-related protein in human cells involved in as-
sembly of spliceosome, as well as a deubiquitinating en-
zyme without protease activity [13,14]. Although USP39
included the ubiquitin enzyme area but without de-
ubiquitinating enzymes activity. USP39 plays an important
role in the maintenance of mitotic spindle checkpoint
function. The function is that it strictly controlled the ac-
tivity of ubiquitin ligase. And only when all chromosomes
are attached to the spindle in anaphase of mitosis, it will
release the ubiquitin ligase activity [15]. As is known, the
spliceosome consists of five small nuclear ribonucleopro-
teins (snRNPs), U1, U2, U4, U5 and U6, along with many
non-snRNP proteins. Human USP39 protein is a tri-
snRNP-specific protein, which is essential for recruitment
of the tri-snRNP to the pre-spliceosome [16]. USP39 is
highly conserved, with 65% homology to the yeast Sad1p.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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snRNP and splicing both in vivo and in vitro [13,14].
The gene mutation of USP39 can cause that the muta-
tion of retinoblastoma rb1 mRNA splicing is blocked,
and leading to the occurrence of pituitary adenoma [17].
It showed that the down-regulation of USP39 gene can
cause rb1 mRNA splicing abnormalities, which then
leaded to downstream target genes e2f4 up-regulated in
zebrafish. It is well known that e2f4 is a main regulator,
it has the strong ability to cause tumor formation when
it is overexpressed.
Previous studies found that down-regulation of USP39
could inhibit cell growth and colony formation of human
breast cancer cells [18]. USP39 is also involved in the pro-
liferation of prostate cancer cells and its SUMOylation is
important for its function [19]. However, there is no re-
port about the functions of USP39 in human hepatocellu-
lar carcinoma. In this study, taking advantage of lentivirus
mediated RNAi, we inhibited the expression of USP39 in
SMMC-7721 cells. We then analyzed the functions of
USP39 in SMMC-7721 cell growth and colony formation.
Furthermore, we checked the cell cycle progression after
knock-down of USP39.
Results
Expression of USP39 was suppressed efficiently in SMMC-
7721 cells by lentivirus mediated RNAi
To investigate the potential functions of USP39 in HCC,
we knocked down USP39 in SMMC-7721 cells using
lentivirus-mediated gene transfection. As shown in
Figure 1A, most SMMC-7721 cells presented GFP-Figure 1 Expression of USP39 is suppressed efficiently in SMMC-7721
Lv-shCon and Lv-shUSP39 infected SMMC-7721 cells under fluorescence micro
mRNA levels of USP39 in Con, Lv-shCon and Lv-shUSP39 infected SMMC-772
analysis of protein levels of USP39 in in Con, Lv-shCon and Lv-shUSP39 infectpositive signals after infected by lentivirus recombined with
shRNA targeting USP39 (Lv-shUSP39) or control scram-
bled shRNA (Lv-shCon), indicating that the recombinant
lentivirus we got could infect SMMC-7721 cells with high
efficiency. Further Real-time PCR and western-blot analysis
suggested that the mRNA and protein levels of USP39
were both down-regulated significantly in Lv-shUSP39 in-
fected SMMC-7721 cells (Figure 1B and C). The mRNA of
USP39 was only 27% of that in control or Lv-shCon in-
fected SMMC-7721 cells. No USP39 protein band was
detected in Lv-shUSP39 infected cells. The above results
indicated that recombinant lentivirus taking shUSP39
could effectively suppress the expression of endogenous
USP39 in HCC cells.
Down-regulation of USP39 inhibited cell proliferation and
colony formation ability of SMMC-7721 cells
To study whether USP39 was related with SMMC-7721 cell
proliferation, we performed 5-day MTT assay. Lv-shUSP39
infected SMMC-7721 showed slower growth rate com-
pared with control and Lv-shCon infected cells (Figure 2A).
On day 5, OD595 of Lv-shUSP39 infected cell was only
3.51 ± 0.12, while that of control and Lv-shCon infected
cells were 5.31 ± 0.10 and 5.24 ± 0.53, respectively. We then
analyzed the colony formation ability of SMMC-7721 cells
after lentiviral infection using crystal violet staining. The
cell number in a single colony was significantly reduced
after Lv-shUSP39 infection (Figure 2B). Furthermore, we
calculated the number of colons formed after lentivirus in-
fection. The colony number of LvshUSP39 infected
SMMC-7721 cells was only 46 ± 8, compared with that ofcells after Lv-shUSP39 infection. (A) Representative images of Con,
scope. Left, bright field; right, GFP. Scale bar, 10 μm. (B) qRT-PCR analyzed
1 cells. Actin was used as control gene. **, P < 0.01. (C) Western blotting
ed SMMC-7721 cells. GAPDH was used as control protein.
Figure 2 Down-regulation of USP39 inhibits cell proliferation and colony formation ability of SMMC-7721 cells. (A) The growth curves of
Con, Lv-shCon and Lv-shUSP39 infected SMMC-7721 cells. **, P < 0.01. (B) Representative images of colony formation assays of Con, Lv-shCon
and Lv-shUSP39 infected SMMC-7721 cells. From top to bottom: crystals violet staining, bright field and GFP of single colony, and crystals violet
staining of six-well plate. Scale bar, 25 μm. (C) Colony numbers of Con, Lv-shCon and Lv-shUSP39 infected SMMC-7721 cells. ***, P < 0.001.
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cells (Figure 2C). Furthermore, these results suggested that
suppression of USP39 could inhibit cell proliferation and
colony formation of HCC cells.
Down-regulation of USP39 impaired cell cycle
progression of SMMC-7721 cells
To find out the underlying mechanisms of inhibition of
cell proliferation and colony formation, we analyzed
phases of cell cycle of SMMC-7721 cells after USP39
knockdown using flow cytometry with PI staining. As
shown in Figure 3A and B, 43.44 ± 0.55% of cells were at
G0/G1 phase in Lv-shUSP39 infected SMCC-7721 cells,
which were significantly lower than those of control cells
(57.78 ± 0.18%, p value) and Lv-shCon infected cells
(58.28 ± 0.26%, p value). Meanwhile, there were more cells
at G2/M phase after Lv-shUSP39 infection (30.20 ± 0.46%),
compared with control cells (20.20 ± 0.43%) and Lv-shCon
infected cells (18.52 ± 0.54%). These results indicated that
cell cycle progression was impaired in USP39 knock-down
HCC cells. In addition, 5.02 ± 0.09% cells were detected at
sub-G1 phase in Lv-shUSP39 infected SMMC-7721 cells,
much higher than those in control cells (0.79 ± 0.04%) and
Lv-shCon infected cells (0.77 ± 0.05%) (Figure 3C), sug-
gesting that there were more apoptotic cells after USP39
knock-down.
Down-regulation of USP39 induced SMMC-7721 cells
apoptosis
To further confirm the influence of USP39 on cell apop-
tosis, we used Annexin V-APC/7-AAD double staining onSMMC-7721 cells following lentivirus infection. Annexin
V-APC vs 7-AAD plots from the gated cells showed the
populations corresponding to viable (Annexin V-/AAD-),
necrotic (Annexin V–/7-AAD+), early apoptotic (Annexin
V+/7-AAD–), and late apoptotic (Annexin V+/7-AAD+)
cells. The group of silencing USP39 increased the apop-
totic cells (early apoptosis and late apoptosis) by 13-fold,
as compared to the group of shCon (Additional file 1:
Figure S1A and B). Therefore, These results demon-
strated that USP39 gene interference induced a strong
pro-apoptotic effect in human hepatocellular carcinoma
SMMC-7721 cells. Thus, we may conclude that USP39
is involved in signaling pathways that intervene hepato-
cellular carcinoma cell apoptosis.Down-regulation of USP39 altered the expression of
apoptotic proteins of SMMC-7721 cells
As shown in Figure 3C, knockdown of USP39 observ-
ably caused increased percentage of SMMC-7721 cells
in the sub-G1 phase which represents apoptotic cells (p
< 0.001). The expression change of apoptosis genes have
been detected in SMMC-7721 cells after USP39 knock-
down, including Bax, Caspase 9, Caspase 3 and PARP by
western blot. It showed that knockdown of USP39 re-
sulted in a significantly increase in the expressin of Bax,
Caspase 9, Caspase 3 and PARP (Additional file 2:
Figure S2). These results suggested that knockdown of
USP39 in SMMC-7721 cells could induce cell apoptosis
via altering the expression of Bax, Caspase 9, Caspase 3
and PARP.
Figure 3 Down-regulation of USP39 impairs cell cycle progression of SMMC-7721 cells. (A) Representative graphs of flow cytometry analysis
of SMMC-7721 cell cycle using PI staining. (B) Statistic analysis of percentages of SMMC-7721 cells at different cell cycle stages (G0/G1, S and G2/M).
(C) Statistic analysis of percentages of sub-G1 SMMC-7721 cells. ***, P < 0.001.
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Human hepatocellular carcinoma (HCC) is the most
popular type of liver cancer, which is mainly caused by
viral infection and is the third leading cause of cancer-
related death [1-3]. It ranks as one of the top reasons of
cancer related death all over the world [4,5]. The high
rate of tumor recurrence and intrahepatic metastasis
lead to poor prognosis of HCC patients [2]. RNAi, with
the high specific and no apparent toxicity, is a promising
gene therapeutic methods for the treatment of cancer in
the furture [20]. Molecular targets are needed to be dis-
covered for the treatment of hepatocellular carcinoma.
Cell growth and colony formation are two important
indexes for tumorigenesis. Our studies indicate a defect
of cell growth and colony formation of HCC cells after
knock-down of USP39, which is similar to previous re-
ports of USP39 in breast cancer cells [18]. Flow cytome-
try showed that down-regulation of USP39 resulted in
arrest of SMMC-7721 cells at G2/M phase and more apop-
tosis. In consistent with our results, suppression of USP39
in MCF-7 cells leads to impaired cell cycle [18]. In
addition, flow cytometry analysis using Annexin V-APC/7-
AAD was applied to confirm the influence of USP39 on
cell apoptosis. Downregulation of USP39 induced a re-
markable pro-apoptotic effect in human hepatocellular car-
cinoma SMMC-7721 cells. Therefore, we could draw the
conclusion that USP39 silencing led to the proliferationinhibition in human hepatocellular carcinoma presumably
as a result of the induction of apoptosis. Furthermore,
western blot showed that depletion of USP39 distinctly up-
regulated the expression of Bax, which pertains to the Bcl-
2 family of pro-apoptotic proteins [21], and also aug-
mented the protein expression levels of Caspase 9, Caspase
3 and cleaved PARP that are key apoptosis-associated pro-
teins, especially the cleaved-PARP is considered to be a
marker of apoptosis [22,23]. It further confirmed that
knockdown of USP39 could suppress the growth of hepa-
tocellular carcinoma cells through inducing cell apoptosis.
Sad1, the homologue of USP39 in yeast, could control
multiple checkpoints of cell cycle [24]. Mutations of
Sad1 affect both the spindle formation and function, as
well as splicing [25,13]. Van Leuken et al. found that
USP39 is a new factor required to maintain the spindle
checkpoint and support successful cytokinesis through
regulating of Aurora B mRNA splicing in mammalian
cells [15]. Aurora B is a Ser/Thr kinase and supports the
assembly of a functional bipolar spindle. Silencing the
Aurora B using RNAi suppresses the activity of PI3K/
Akt/NF-kB signaling pathway and inhibits proliferation,
migration and invasion of various carcinoma cells
[26-28]. Aurora B inhibitors have the antitumor activity
and some of them have been tested in clinical trials in
patients with solid tumors and acute myeloid leukemia
[29-31]. In USP39 depleted U2OS cells, the mRNA level of
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in spindle checkpoint function and cytokinesis [15]. These
evidences suggest USP39 might control cell proliferation
through regulating Aurora B or other mRNA splicing.
One method to treat cancer is to induce apoptosis of can-
cer cells. Lv-shUSP39 infected SMMC-7721 cells showed
increased sub-G1 phase cells, which are usually considered
as an indicator of apoptotic fragmentation. USP39 knock-
down MCF-7 cells present similar phenotype [18]. In
addition, mutations of yeast Sad1is related with yeast cell
viability and deletion of Sad1 is lethal [25]. Although lenti-
virus could efficiently deliver shRNA into mammalian cells
and silencing USP39 in carcinoma cells, targeted gene de-
livery methods are need to be developed to specifically
knockdown USP39 expression in tumor cells.
Conclusions
In conclusion, our studies indicated that suppression of
USP39 through recombinant lentivirus taking shUSP39
inhibited cell proliferation and colony formation of HCC
cells along with cell cycle arrest at G2/M phase. These
results suggest that USP39 may be a potential target
gene for treatment of HCC.
Methods
Cell lines and culture conditions
HCC cell line SMMC-7721 and human embryonic kidney
cell line 293 T (HEK293T) were obtained from Cell Bank of
Chinese Academy of Sciences (Shanghai, China). Both of
the cell lines were maintained in Dulbecco’s modified Eagle’s
medium (DMEM, Hyclone, SH30243.01B+) plus 10% fetal
bovine serum (FBS, Biowest, S1810) and 100 U/ml of
penicillin-streptomycin. The cells were incubated at 37°C in
a humidified atmosphere of 5% CO2. All experimental re-
searches handling human cells were carried out in compli-
ance with the Tenets of the Declaration of Helsinki.
Lentivirus packaging and transduction
Short hairpin RNA (shRNA) targeting human USP39 gene
(NM_001256725.1) was designed as following, 5′-CCT
TCCAGACAACTATGAGATCTCGAGATCTCATAGTTG
TCTGGAAGGTTTTT-3′. The control scrambled shRNA
was 5′-GCGGAGGGTTTGAAAGAATATCTCGAGATAT
TCTTTCAAACCCTCCGCTTTTTT-3′. Both shRNAs
were inserted into the vector pFH-L (Shanghai Hollybio,
China) between restriction enzyme site NheI and PacI. The
shRNA taking plasmid together with two helper plasmids,
pVSVG-I and pCMVΔR8.92 (Shanghai Hollybio, China),
were transfected into the HEK293T cells using Lipofecta-
mine 2000 (Life technologies, USA). Two days after trans-
fection, cell culture media was collected and concentrated.
The recombinant lentivirus was stored at -80°C.
SMMC-7721 cells were incubated in a six-well plate at an
inoculation density of 5 × 104 cells/well. The recombinantlentivirus containing media were added into the SMMC-
7721 cells with a multiplicity of infection (MOI) of 30.
Infection efficiency was determined through counting
the numbers of GFP-positive cells under fluorescence
microscope at 96 h after lentiviral infection.
qRT-PCR
Primers 5′-GCCAGCAGAAGAAAAAGAGC-3′ (forward)
and 5′- GCCATTGAACTTAGCCAGGA-3′ (reverse) were
designed to detect USP39 expression. Actin was used as
endogenous control and primers were 5′- GTGGACATC
CGCAAAGAC -3′ (forward) and 5′- AAAGGGTGTAAC
GCAACTA -3′ (reverse). Six days after lentiviral infection,
SMMC-7721 cells were harvested and total RNA was ex-
tracted using TRIzol (Life technologies, USA) according
to the manufacturer’s instructions. Single strand cDNA
was obtained using M-MLV reverse transcriptase kit
(Promega, USA). USP39 mRNA level was then mea-
sured by qRT-PCR with SYBR master mixture (Applied
Biosystems) on BioRad Connect Real-Time PCR platform.
The 20 μl PCR reaction mixture was: 10 μL 2XSYBR pre-
mix ex taq, 0.8 μLprimers (2.5 μM), 5 μL cDNA and
4.2 μL ddH2O. The detailed PCR program was: initial de-
naturation at 95°C for 1 min; denaturation 95°C, 5 s; an-
nealing extension of 60°C, 20 s (a total of 40 cycles). The
absorbance values were read at the extension stage. Fold
changes in expression have been calculated using the
2-ΔΔCt method. Experiments were performed at least three
times.
Western blotting
Six days after lentiviral infection, SMMC-7721 cells were
collected, washed with ice-cold PBS and lysed in 2× SDS
sample buffer (100 mM Tris-Hcl (pH 6.8), 10 mM EDTA,
4% SDS, 10% Glycine). Equal amount of protein samples
(30 μg) were run on the 10% SDS-PAGE gel at 50 V for
3 h. The proteins were then transferred to polyvinylidene
fluoride (PVDF) membrane at 300 mA for 1.5 h. The
membrane was blocked by 1% bovine serum albumin
(BSA) in TBST at RT for 1 h and incubated with primary
antibodies, mouse anti-USP39 (1:100, Sigma Aldrich,
SAB1407042) , rabbit anti-PARP (1: 1000, Cell Signaling
Technology, #9542), rabbit anti-Caspase 3 (1: 500, Cell
Signaling Technology, #9661), rabbit anti- Caspase 9
(1:1000, Proteintech Group Inc., 10380-1-AP), rabbit
anti-Bax (1: 500, Cell Signaling Technology, #2774) and
rabbit anti-GAPDH (1:100,000, Proteintech Group Inc.,
10494-1-AP) overnight at 4°C. After washed by TBST,
membranes were incubated with horseradish peroxidase
conjugated goat anti-mouse (1:5,000, Santa Cruz, SC-2005)
and goat anti-rabbit (1:5,000, Santa Cruz, SC-2054) sec-
ondary antibodies for 2 h at room temperature. The
membrane was washed by TBST and signals were de-
tected by enhanced chemiluminescence kit (Pierce).
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Lentiviral infected SMMC-7721 cells were seeded in 96-well
plates at an inoculation density of 3,000 cells/well. At different
time points after incubation (1, 2, 3, 4 and 5 days), MTT (3-
(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
solution was added to each well and incubated at 37°C for
4 h. Then 100 μL acidic isopropanol (10% SDS, 5% isopropa-
nol and 0.01 mol/L HCl) was added into each well after the
medium were carefully removed. Plates were then read at a
wavelength of 595 nm. Experiments were performed at least
three times.Colony formation assay
Lentiviral infected SMMC-7721 cells were seeded in 6-
well plate at an initial density of 600 cells/well. Cells
were cultured in 5% CO2 incubator for 8 days at 37°C.
After wash by ice-cold PBS and fixation with 4% PFA,
crystals purple staining was performed according to the
instruction.Cell cycle assay
Lentiviral infected SMMC-7721 cells were seeded in 6 cm
dishes at initial density of 80,000 cells/dish. After incuba-
tion at 37°C for 40 h, the cell confluence reached ~80%.
SMMC-7721 cells were then collected, washed in cold
PBS and fixed with pre-cold 75% ethanol. After digestion
using RNase, the cells were stained with Propidium iodide
(PI). Cell cycle distribution was then analyzed by using a
flow cytometer (BD Biosciences). Experiments were per-
formed at least three times.Cell apoptosis assay by flow cytometry
SMMC-7721 cells were subjected to three different
treatments (Con, Lv-shCon, and Lv-shUSP39). After
96 h of incubation, cells were washed by PBS and re-
seeded in 6 cm dishes at a density of 8 × 104 cells/dish
before detection. After 48 h, the cells were collected,
washed with PBS for three times and subjected to
Annexin V-APC/7-AAD double staining according to the
instruction of Apoptosis Assays Kit (KeyGEN Biotech,
Nanjing, China). Flow cytometry analysis was performed
on FACS caliber II sorter and Cell Quest FACS system
(BD Biosciences, USA).Statistical analysis
Comparisons between groups were done using paired
Student’s t test, and differences were considered statisti-
cally significant at P < 0.05. Data were presented as
mean ± standard deviation (SD) of three independent
experiments.Ethical standards
This study was also reviewed and approved by the
Institutional Review Board of Eastern Hepatobiliary
Hospital.
Additional files
Additional file 1: Figure S1. Down-regulation of USP39 induced
SMMC-7721 cells apoptosis. A. Cytogram of Annexin V-APC binding vs. 7-AAD
uptake in SMMC-7721 cells (Con, Lv-shCon and Lv-shGPR137). B. Percentage
of apoptotic cells in SMMC-7721 cells by FACS. Annexin V-/7-AAD-: viable cells,
Annexin V-/7-AAD+: necrotic cells, Annexin V+/7-AAD-: early apoptotic cells;
Annexin V+/7-AAD+: late apoptotic cells.
Additional file 2: Figure S2. Down-regulation of USP39 altered the
expression of apoptotic proteins of SMMC-7721 cells. Western blotting
analysis of apoptosis protein expression levels of Bax, Caspase 9, Caspase
3 and PARP in in Con, Lv-shCon and Lv-shUSP39 infected SMMC-7721
cells. GAPDH was used as control protein.
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